THERABRON
Therabron Therapeutics, we are working to change how respiratory diseases are managed. We are aiming to not only provide symptomatic relief, but also to improve long-term health outcomes and reduce healthcare costs. A privately held, clinical-stage, biopharmaceutical corporation, Therabron is developing a new class of drugs from the secretoglobin family of proteins. Our lead product, recombinant human CC10 protein (rhCC10), is a potent anti-inflammatory agent for patients with respiratory diseases.
THERABRON
Industry:
Biotechnology Medical Therapeutics
Founded:
2007-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.therabron.com
Total Employee:
11+
Status:
Active
Contact:
(240) 205-7271
Email Addresses:
[email protected]
Total Funding:
17.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Apps For Business Google Maps GoDaddy DNS Google Google Maps API Google Cloud Facebook Sharer
Similar Organizations
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Current Employees Featured
Founder
Investors List
Brace Pharma
Brace Pharma investment in Series B - Therabron
Brace Pharma
Brace Pharma investment in Series B - Therabron
Official Site Inspections
http://www.therabron.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
